ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 78 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is 13.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $683 | -99.9% | 1,842,280 | -27.3% | 0.00% | -50.0% |
| Q3 2022 | $1,268,000 | +9.3% | 2,535,439 | +27.6% | 0.00% | +100.0% |
| Q2 2022 | $1,160,000 | +100.0% | 1,986,288 | +144.0% | 0.00% | 0.0% |
| Q1 2022 | $580,000 | -55.0% | 814,025 | -16.6% | 0.00% | -50.0% |
| Q4 2021 | $1,288,000 | -47.4% | 976,005 | -8.3% | 0.00% | -33.3% |
| Q3 2021 | $2,448,000 | +457.6% | 1,064,379 | +964.4% | 0.00% | +200.0% |
| Q2 2021 | $439,000 | -41.3% | 100,000 | -42.2% | 0.00% | 0.0% |
| Q4 2020 | $748,000 | +358.9% | 173,073 | +337.7% | 0.00% | – |
| Q3 2020 | $163,000 | -95.7% | 39,540 | -93.7% | 0.00% | -100.0% |
| Q2 2020 | $3,782,000 | +95.3% | 630,400 | +145.1% | 0.00% | +50.0% |
| Q1 2020 | $1,937,000 | +494.2% | 257,200 | +985.2% | 0.00% | – |
| Q4 2019 | $326,000 | – | 23,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
| RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
| Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
| Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
| Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
| Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |